Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1 - Wikidata - wikimedia - TriplyDB

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

http://www.wikidata.org/entity/Q37111703

about

Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease Insulin resistance in clinical and experimental alcoholic liver disease Toxicant-associated steatohepatitis Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury Involvement of AMPK in alcohol dehydrogenase accentuated myocardial dysfunction following acute ethanol challenge in mice Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.The emerging role of autophagy in alcoholic liver disease.Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.PKCε contributes to chronic ethanol-induced steatosis in mice but not inflammation and necrosis.Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis."Second hit" models of alcoholic liver disease.Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice.Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases Deficiency in AMPK attenuates ethanol-induced cardiac contractile dysfunction through inhibition of autophagosome formation.Acute alcohol-induced liver injury.Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.Binge ethanol and liver: new molecular developments Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis Metformin inhibits the growth of human pancreatic cancer xenografts Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.Molecular mechanisms of alcoholic fatty liver New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.Mechanisms and cell signaling in alcoholic liver disease.Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice.New role of resistin in lipopolysaccharide-induced liver damage in mice.PKCepsilon plays a causal role in acute ethanol-induced steatosis Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study.Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.

P2860

Q22241963-CE27CDA5-CFF4-4928-B217-BE1FF2216206 Q26769611-90A28CE4-37BA-4ADD-BC13-A446643C6059 Q26769622-DCE3AAC2-88F0-430E-AD1D-23AB4243AA53 Q26852498-73420E82-BFD9-4BFB-AC8F-03088C3D09FD Q26865988-790D4F1E-7217-4F1C-97D3-077D1BFD2377 Q27687049-6360ADAF-83FC-4F62-AFED-6DBECEB1E7F2 Q28071500-DF21B69F-22E5-42F4-94C1-4A5A9A875BC7 Q28474635-37DA4C7D-EC09-4FFC-BA0C-CA4F1FF1A567 Q30428511-57F63EA7-BBF0-4C78-A4EA-EBA91904AEA8 Q33602167-97C72207-5E19-4E8D-B04C-E44F8329584A Q33603645-D070572E-E745-498D-A2E3-5824229CD42D Q33840622-C533906E-DA16-4020-A3CA-8529784DD62E Q33894424-D9BC0C6E-0C50-4F60-BF7B-A79B19B67CC8 Q33960260-444FB3AC-6DEB-4580-9E90-E188B698C7AB Q34147825-369CED5C-1865-41A3-B12D-25A0E591EAEF Q34339711-A7B3EA4A-AB70-4A26-A93D-C09B8A31A8CB Q34342131-A6021134-52B2-4C76-91DD-322E777A4ED1 Q34405039-54D18337-FCD4-48C6-9D90-3F7273C4159E Q34781469-D2EFDAF4-D858-4FE7-B707-335461C9A355 Q35029506-83540424-6C8A-4E99-A08B-B33F5B133BBA Q35597576-242F9A21-F6DA-4944-91F4-75B54A34D252 Q35691565-A659491C-0A36-4358-9B58-E44CA0172102 Q35858073-F9E06B23-3959-4029-96A3-A5FEC05BC727 Q35965054-9679669B-6393-4132-ADB1-DCAC5A5EF0F8 Q36025557-ADCF8D48-0CAA-4E03-9970-165DC3CBCE93 Q36464940-B84EE697-3957-4E22-8A1B-E0EFAEA3C8E9 Q36572087-146D0898-4C18-4CC4-AB11-DB9B38CA99AF Q36798710-4CD77F31-2BE3-415B-842F-C785597CCE97 Q36818022-1A5DB260-B8E0-4896-95D5-14A4FCEA5E62 Q36927078-A62B6449-F384-4384-AF48-8737D2BF1B6A Q37018313-A77FF592-E769-4BE7-A27C-A9E547CE5BDA Q37078754-DF0A7A09-A6E3-40C9-9343-F1DDF453397D Q37108878-E38275F8-F22F-490D-8376-A1150D6882CD Q37127404-4404991B-E9CF-41ED-B347-8B6C746FB695 Q37139288-478E86EA-03E7-4AD1-8E9D-50B49F21E1D5 Q37140377-429B4591-DE70-4B75-8FF8-F34108D1095D Q37167907-8CCC8A67-11A6-4B95-B054-41B250387449 Q37193192-75370B27-73EA-4C2C-9AB3-9D4C811C754F Q37245516-1F848D61-EB4D-4E5A-ABDF-39BBF2804D32 Q37305691-1583E2D2-DCF7-4F0F-9703-1EE43EBA7839

P2860

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

http://www.wikidata.org/entity/Q37111703

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metformin prevents alcohol-ind ...... sminogen activator inhibitor-1

@en

Metformin prevents alcohol-ind ...... minogen activator inhibitor-1.

@nl

type

label

Metformin prevents alcohol-ind ...... sminogen activator inhibitor-1

@en

Metformin prevents alcohol-ind ...... minogen activator inhibitor-1.

@nl

prefLabel

Metformin prevents alcohol-ind ...... sminogen activator inhibitor-1

@en

Metformin prevents alcohol-ind ...... minogen activator inhibitor-1.

@nl

P1433

Q37111703-2C6F6189-8CD0-4F9B-AE19-AE9C6827C0C5

P1476

Q37111703-92C26F8A-4958-4FD5-A2CC-B7A4169172AB

P2093

Q37111703-012C2062-C297-485B-9A87-31BCC8050C0E

Q37111703-3FD8684D-2C30-4335-BC03-4DD0D03C8240

Q37111703-5536CC90-3A48-4BD7-B8CF-F033CF284578

Q37111703-853E4124-645B-419F-8ED0-145533128DD5

Q37111703-9FB23DFF-7E29-4ABD-9C86-BE63156B4092

Q37111703-AE8A656E-3E8D-449E-A2A4-BFA79D9A2EB8

Q37111703-C2CA47DF-EAF4-4EB9-918F-73B065073B58

Q37111703-CA6CFEBA-DA7C-4C12-935E-F63EA4CE5506

Q37111703-D459945A-13DD-4BCA-AD58-90C43E53EC08

P2860

Q37111703-0FB71DF4-E3CE-4580-9D9C-969C5CD701BD

Q37111703-199BC489-5F65-4566-BFB4-FE08D3567061

Q37111703-1FE4C856-89FD-4050-B35D-C674BDA6CEDD

Q37111703-20BE11B6-C552-42EE-9B0D-18FCE2820E10

Q37111703-25869BEB-6A23-4A40-9B6F-E2DF71CE9828

Q37111703-26332FB6-90A4-4EC7-A8A7-606448DD33FD

Q37111703-27D5F32E-191C-4C02-A0D4-E9551D53CC5D

Q37111703-2A523006-0D9C-4CF6-A94A-2FDB2DD511E7

Q37111703-366255D7-5BB8-48E3-964A-5750C5AB6DE9

Q37111703-374E5959-1E72-405F-938F-3BFF1C1D8967

P304

Q37111703-017CA54B-2D53-44AD-B659-093A5CC87A10

P31

Q37111703-10C8A542-3B23-422B-835B-C974BE5DED4B

P356

Q37111703-9BE16EEE-35B7-4DEB-A182-AF2F4EE770E3

P407

Q37111703-EEFD13D0-39A7-422F-90BB-658F0F97255E

P433

Q37111703-E5631088-B649-4BAF-B5D0-D62ADEC5171C

P478

Q37111703-E3C8DDC8-25E5-4105-9486-DDE4798DA641

P577

Q37111703-37386061-FFD7-4E52-8290-FE21311C5780

P5875

Q37111703-2755A690-1C36-4C31-A25B-7C1B85B34CE6

P698

Q37111703-68CBAF75-5D53-4B8A-BFAD-4B7C54A009CF

P921

Q37111703-C5F90F6D-B4D7-4360-BA96-30916D03246A

P932

Q37111703-E3DCD53B-F12C-46B3-BEE1-8115168229EC

P356

J.GASTRO.2006.03.020

P1433

Gastroenterology

P1476

Metformin prevents alcohol-ind ...... sminogen activator inhibitor-1

@en

P2093

Gavin E Arteel

http://www.w3.org/2001/XMLSchema#string

Ilinca Duveau

http://www.w3.org/2001/XMLSchema#string

Ina Bergheim

http://www.w3.org/2001/XMLSchema#string

James P Luyendyk

http://www.w3.org/2001/XMLSchema#string

Jason C Lambert

http://www.w3.org/2001/XMLSchema#string

Juliane I Beier

http://www.w3.org/2001/XMLSchema#string

Luping Guo

http://www.w3.org/2001/XMLSchema#string

Molly Anne Davis

http://www.w3.org/2001/XMLSchema#string

Robert A Roth

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

Fat and the liver--a molecular overview.

Oxidants and antioxidants in alcohol-induced liver disease.

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

P304

2099-2112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2006.03.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7019949

http://www.w3.org/2001/XMLSchema#string

P698

16762632

http://www.w3.org/2001/XMLSchema#string

P921

P932

2648856

http://www.w3.org/2001/XMLSchema#string